Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
898.15
Change Change %
8.20 0.92%

Updated:03 Dec, 2020, 15:59 PM IST

BSE
900.80
Change Change %
11.75 1.32%

Updated:03 Dec, 2020, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Citi
N/A
19-03-2015 Buy 1262.10 1945.00
N/A
Closed Custom
19-03-2016

Citi maintains buy on Aurobindo Pharma

Aurobindo Pharma is the top mid-cap pharma pick. Expect strong earnings per share growth for FY14-17. Company has been improving its balance sheet to drive re-rating.

Top
Listen to the latest songs, only on JioSaavn.com